Insulin-like growth factor-1 increases endothelin receptor A levels and action in cultured rat aortic smooth muscle cells. 2005

Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taiwan. cfkwok@vghtpe.gov.tw

Insulin is known to cause an increase in endothelin-1 (ET-1) receptors in vascular smooth muscle cells (SMCs), but the effect of insulin-like growth factor 1 (IGF-1) on ET-1 receptor expression is not known. We therefore carried out the present study to determine the effect of IGF-1 on the binding of ET-1 to, and ET type A receptor (ETAR) expression and ET-1-induced 3H-thymidine incorporation in, vascular SMCs. In serum-free medium, IGF-1 treatment increased the binding of 125I-ET-1 to SMC cell surface ET receptors from a specific binding of 20.1%+/-3.1% per mg of protein in control cells to 45.1%+/-8.6% per mg of protein in cells treated with IGF-1 (10 nM). The effect of IGF-1 was dose-related, with a significant effect (1.4-fold) being seen at 1 nM. The minimal time for IGF-1 treatment to be effective was 30 min and the maximal effect was reached at 6 h. Immunoblotting analysis showed that ETAR expression in IGF-1-treated cells was increased by 1.7-fold compared to controls. Levels of ETAR mRNA measured by the RT-PCR method and Northern blotting were also increased by 2-fold in IGF-1-treated SMCs. These effects of IGF-1 were abolished by cycloheximide or genistein. Finally, ET-1-stimulated thymidine uptake and cell proliferation were enhanced by IGF-1 treatment, with a maximal increase of 3.2-fold compared to controls. In conclusion, in vascular SMCs, IGF-1 increases the expression of the ET-1 receptor in a dose- and time-related manner. This effect is associated with increased thymidine uptake and involves tyrosine kinase activation and new protein synthesis. These findings support the role of IGF-1 in the development of atherosclerotic, hypertensive, and diabetic vascular complications.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings

Related Publications

Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
November 1995, The Journal of biological chemistry,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
May 2010, Canadian journal of physiology and pharmacology,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
June 1998, Diabetes,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
December 1994, Experimental cell research,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
January 1997, Life sciences,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
November 2000, Metabolism: clinical and experimental,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
April 1995, Biochimica et biophysica acta,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
September 1993, Endocrinology,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
September 2009, Atherosclerosis,
Ching Fai Kwok, and Chi-Chang Juan, and Kuang-Chung Shih, and Chii-Min Hwu, and Tjin-Shing Jap, and Low-Tone Ho
July 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
Copied contents to your clipboard!